Delivery Order SPE2DB22D1202-SPE2DB25FUGH9

Award Date 10/24/24
Potential Completion Date 10/25/24
Potential Value $6.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,047.90 firm-fixed-price delivery order is for the procurement of 24 units of the medication SCOPOLAMINE 1 MG/3 DAY PATCH. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,563.18 firm fixed price delivery order is for the supply of SCOPOLAMINE 1 MG/3 DAY PATCH 10S, a medical product, with a performance period ending on January 15, 2025. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,755.54, is a delivery order for the supply of SCOPOLAMINE 1 MG/3 DAY PATCH 4S, a specialized medical product. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,665.36 firm fixed-price delivery order, awarded on September 4, 2024, is for the supply of scopolamine 1 mg/3 day patches. The contract has an ultimate completion date of September 5, 2024, and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,204.08, is a Firm Fixed Price Delivery Order for 4,567,673,519 units of SCOPOLAMINE 1 MG/3 DAY PATCH 10S. The award has a completion date of March 25, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,588.01 firm-fixed-price delivery order is for the supply of SCOPOLAMINE 1 MG/3 DAY PATCH 10S, a medical product, with a completion date of January 23, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,131.20 firm fixed-price delivery order is for the supply of SCOPOLAMINE 1 MG/3 DAY PATCH 24S, a medication used to treat motion sickness. The contract has a period of performance through September 4, 2024. Amerisourcebergen, through its Corporate Office division, has been awarded this contract to provide essential pharmaceutical products to...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,530.18, is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 4S, a medical product. The contract has an ultimate completion date of April 2, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,544.44 firm fixed-price delivery order is for the supply of SCOPOLAMINE 1.5MG 10S, a medical commodity. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. The IDC, which runs through...
This federal contract award, with a value of $1,163.88, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 10S, a medical product, and falls under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the DLA Troop Support Medical and the parent company Cencora, Inc. (doing business as Amerisourcebergen). This IDC...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB25FUGH9
    Delivery Order

This federal contract award is for the delivery of SCOPOLAMINE 1 MG/3 DAY PATCH 24S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $6,319.23 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award does not have a set-aside designation, indicating open competition. No subcontractors are mentioned in the information provided.

Generated 1/23/25, 9:32 AM